Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Clinical trial NCT01993719 · COMPLETED
Trial details
- NCT number
- NCT01993719
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2021-10-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.